U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H21N3O2.C7H6O3
Molecular Weight 413.4669
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHYSOSTIGMINE SALICYLATE

SMILES

OC(=O)C1=C(O)C=CC=C1.[H][C@]23N(C)CC[C@@]2(C)C4=C(C=CC(OC(=O)NC)=C4)N3C

InChI

InChIKey=HZOTZTANVBDFOF-PBCQUBLHSA-N
InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
PHYSOSTIGMINE SALICYLATE
EP   JAN   MART.   MI   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
Common Name English
PHYSOSTIGMINI SALICYLAS [WHO-IP LATIN]
Common Name English
PHYSOSTIGMINE SALICYLATE [MI]
Common Name English
ANTILIRIUM
Brand Name English
PHYSOSTIGMINE SALICYLATE [WHO-IP]
Common Name English
PHYSOSTIGMINE SALICYLATE [VANDF]
Common Name English
PHYSOSTIGMINE SALICYLATE [MART.]
Common Name English
PHYSOSTIGMINE SALICYLATE [USP-RS]
Common Name English
ISOPTO ESERINE
Common Name English
NSC-757275
Code English
ESERINE SALICYLATE
Common Name English
Physostigmine monosalicylate
Common Name English
PYRROLO(2,3-B)INDOL-5-OL, 1,2,3,3A,8,8A-HEXAHYDRO-1,3A,8-TRIMETHYL-, METHYLCARBAMATE (ESTER), (3AS-CIS)-, MONO(2-HYDROXYBENZOATE)
Common Name English
PHYSOSTIGMINE SALICYLATE [EP MONOGRAPH]
Common Name English
PHYSOSTIGMINE SALICYLATE [JAN]
Common Name English
PHYSOSTIGMINE SALICYLATE [USP MONOGRAPH]
Common Name English
Physostigmine salicylate [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C47792
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
FDA ORPHAN DRUG 183
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
Code System Code Type Description
CHEBI
27953
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
DRUG BANK
DBSALT001541
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
RS_ITEM_NUM
1537003
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
ChEMBL
CHEMBL94
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
DAILYMED
2046ZRO9VU
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
CAS
57-64-7
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
NSC
757275
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
MESH
C026718
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-343-8
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
RXCUI
33656
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID80883232
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
MERCK INDEX
m8766
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY Merck Index
SMS_ID
100000079464
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
NCI_THESAURUS
C81336
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
FDA UNII
2046ZRO9VU
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
PHYSOSTIGMINE SALICYLATE
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY Description: Colourless crystals; odourless. Solubility: Sparingly soluble in water; soluble in ethanol (~750 g/l) TS; slightly soluble in ether R. Category: Anticholinesterase; miotic. Storage: Physostigmine salicylate should be kept in a tightly closed container, protected from light, and preferably in quantitiesnot exceeding 1 g. Additional information: Physostigmine salicylate is very poisonous. It acquires a red tint when exposed to air or light. All testsshould be performed on freshly prepared solutions. Definition: Physostigmine salicylate contains not less than 98.0% and not more than 101.0% of C15H21N3O2,C7H6O3, calculatedwith reference to the dried substance.
PUBCHEM
5992
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
EVMPD
SUB14865MIG
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
CHEBI
48883
Created by admin on Fri Dec 15 15:16:57 UTC 2023 , Edited by admin on Fri Dec 15 15:16:57 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of Physostigmine
PARENT (SALT/SOLVATE)
Structure of Salicylic acid
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966